ALPA Laboratories LTD
Alpa Laboratories Ltd (ALPA): company summary
The company's annual revenue fell 3.8% year-over-year, while its latest quarter revenue rose 25.2% compared to the same quarter a year earlier.
Alpa Laboratories Ltd (ALPA) is a micro-cap Healthcare company valued at ₹112 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Alpa Laboratories Ltd last traded at ₹53.85, down 3.77% on the day.
- Recent developments
- 2026-09-01: ALPA India highlighted senior pilots' attrition at Air India Group and called for an independent review. 2026-07-20: ALPA India urged the DGCA to suspend Dubai and Abu Dhabi-bound flights due to Middle-East tensions and offered technical support to the DGCA.
- Financial performance
- The company's annual revenue fell 3.8% year-over-year, while its latest quarter revenue rose 25.2% compared to the same quarter a year earlier. Annual net profit dropped 24.9%, but the latest quarter net profit fell 91.7% from the prior year's quarter. The net profit margin narrowed 4.0 percentage points to 14.2%, and return on equity remained at 8.1%.
- Valuation multiples
- The stock trades at 8.0 times earnings, a discount to the Healthcare median of 32.0, 0.73 times book value.
- Things to watch
- The company's latest quarter net profit fell 91.7% from the prior year's quarter. The net profit margin narrowed 4.0 percentage points to 14.2%. The stock is 36.9% below its 52-week high.
- Where it stands
- The company's latest quarter revenue rose 25.2% compared to the same quarter a year earlier, but net profit fell 91.7%. The stock is 36.9% below its 52-week high. The net profit margin narrowed 4.0 percentage points to 14.2%.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by valuation (8.7) and risk (8.3), but held back by momentum (0.2). Valuation looks strong at 8.7, but that is offset by momentum at 0.2. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Low leverage — D/E 0.01
- Profitable in all of the last 5 years
- Undemanding at 8× earnings
- Momentum is weak (0.2/10)
- Revenue barely growing (2% a year)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore ALPA LABORATORIES LTD’s valuation
Free deep-dive tools · no sign-up
ALPA LABORATORIES LTD peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare ALPA LABORATORIES LTD with peers
Related tools & concepts
Value ALPA LABORATORIES LTD with the ratios and calculators DocStoX uses in its analysis.

